Wen, Q, Kim, C, Hamilton, PW and Zhang, S. 2016. Additional file 1 of A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping. [Online]. Figshare. Available from: https://doi.org/10.6084/m9.figshare.c.3624356_D4.v1
Wen, Q, Kim, C, Hamilton, PW and Zhang, S. Additional file 1 of A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping [Internet]. Figshare; 2016. Available from: https://doi.org/10.6084/m9.figshare.c.3624356_D4.v1
Wen, Q, Kim, C, Hamilton, PW and Zhang, S (2016). Additional file 1 of A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping. [Data Collection]. Figshare. https://doi.org/10.6084/m9.figshare.c.3624356_D4.v1
Description
Significant genes associated with HDAC inhibitors. The full list of 104 genes (probesets) and their rank order, obtained in the “simulated experiment” with 4 HDAC inhibitors of the CMap reference profiles.
| Data capture method | Unknown |
|---|---|
| Date (Date published in a 3rd party system) | 11 May 2016 |
| Language(s) of written materials | English |
| Data Creators | Wen, Q, Kim, C, Hamilton, PW and Zhang, S |
|---|---|
| LSHTM Faculty/Department | Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology |
| Participating Institutions | Queen’s University Belfast, Belfast, United Kingdom, STFC Daresbury Laboratory, Daresbury, Warrington, United Kingdom, University of Ulster, C-TRIC Building, Altnagelvin Hospital campus, Glenshane Road, BT47 6SB, Derry/Londonderry, United Kingdom |
| Funders |
|
|---|
| Date Deposited | 04 Jan 2024 17:07 |
|---|---|
| Last Modified | 04 Jan 2024 17:07 |
| Publisher | Figshare |
